This article is more than 5 years old. Information may no longer be current.
Best Practices for Optimizing Postsurgical Outcomes: Symposium Recap
Click Here to Manage Email Alerts
Sponsorship Statement: This continuing medical education activity is jointly sponsored by 
and 
Support Statement: This activity is supported by an educational grant from 
Target Audience: The intended learners for this activity are ophthalmologists and other health care professionals involved in the treatment of patients with ophthalmic disorders.
Learning Objectives:
At the conclusion of this activity participants should be able to:
• Implement presurgical patient care strategies that reduce the risk of postoperative inflammation.
• Evaluate current and emerging topical anti-inflammatory agents for safety, efficacy, and patient comfort.
Course Chair:
John R. Wittpenn, MD
Partner
Ophthalmic Consultants of Long Island
Associate Clinical Professor of Ophthalmology
State University of New York at Stony Brook
Stony Brook, New York
Faculty:
Bennie H. Jeng, MD
Associate Professor of Ophthalmology
Co-Director, Cornea Service
University of California San Francisco
San Francisco, California
Marguerite B. McDonald, MD, FACS
Clinical Professor of Ophthalmology
New York University Langone Medical Center
New York, New York
Michael B. Raizman, MD
Associate Professor of Ophthalmology
Tufts University School of Medicine
Director, Cornea and Cataract Service
New England Eye Center
Boston, Massachusetts
External Reviewer:
Benjamin Chacko, MD
Accreditation:
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Ocular Surgery News® . Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 6, 2012 to March 5, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch and listen to the presentations, complete the posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
John R. Wittpenn, MD
Consulting Fees: Alcon, Allergan, Bausch + Lomb
Fees for Non-CME Services: Allergan, Bausch + Lomb
Bennie H. Jeng, MD
Consulting Fees: Kedrion, Santen
Marguerite B. McDonald, MD, FACS
Consulting Fees: Ace Vision Group, Alcon Laboratories, Allergan, AMO, Bausch + Lomb, Focus Laboratories, ISTA Pharmaceuticals, Merck, Nexis Vision, Santen, TearLab, Topcon
Michael B. Raizman, MD
Consulting Fees: Alcon, Allergan, Avedro, Bausch + Lomb, EyeGate, Ocular Therapeutix
External Reviewer reports the following relationship(s):
Benjamin Chacko, MD
No relevant financial relationships to disclose.
Vindico Medical Education and Ocular Surgery News® staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2012 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Ocular Surgery News® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Ocular Surgery News® . Neither Vindico Medical Education, Ocular Surgery News® , nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.